INmune Bio Inc.
INMB | NASDAQ
$2.29
-$0.04 (-1.72%)
At close: Sep 21, 2026, 4:00 PM ET
$2.38
+$0.09 (+3.93%)
Pre-market:
Sep 22, 2026, 7:37 AM ET
Market Data
Market Cap $60.88M
Enterprise Value $43.87M
Beta 0.94
Average Volume 636.71K
Shares Outstanding (Diluted) 26.72M
Shares Change YoY 14.68%
Institutional Ownership 20.23%
Exchange NASDAQ
ISIN US45782T1051
Price Performance
Price Change 1M 0.4%
Price Change 3M 61.3%
Price Change 6M 87.7%
Price Change YTD 48.7%
Price Change 1Y 15.7%
Price Change 3Y -66.7%
Price Change 5Y -88.6%
1M CAGR (ann.) 9.6%
1Y CAGR (ann.) 16.2%
5Y CAGR (ann.) -34.7%
All-Time CAGR -15.1%
Valuation
PE Ratio -3.32
Forward PE N/A
PEG Ratio -0.03
Forward PEG -0.08
PS Ratio N/A
Forward PS 6.40
PB Ratio 2.99
P/FCF Ratio -3.09
P/Adj. FCF Ratio -2.98
P/OCF Ratio -4.09
EV/Sales N/A
EV/EBIT -2.56
EV/EBITDA -2.37
EV/FCF -2.23
Earnings Yield -30.1%
FCF Yield -32.4%
Adj. FCF Yield -33.6%
Financial Health
Net Cash $17.01M
Total Debt $1.41M
Cash & Short-Term Investments $18.41M
Total Assets $26.85M
Current Ratio 4.04
Quick Ratio 4.04
Debt / Equity Ratio 0.07
Debt / EBITDA -0.08
Debt / FCF -0.07
OCF / Debt -13.08
Interest Coverage 0.00
Altman Z-Score -6.92
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -3.8%
Returns
Return on Assets -68.6%
Return on Equity -82.9%
Return on Invested Capital -92.8%
Return on Capital Employed -96.4%
Return on Tangible Assets -68.6%
Historical Growth (CAGR)
Revenue CAGR 3Y -94.4%
Revenue CAGR 5Y -61.1%
Revenue CAGR 10Y 20.2%
EPS CAGR 3Y 39.2%
EPS CAGR 5Y 8.7%
EPS CAGR 10Y -17.9%
FCF CAGR 3Y 6.6%
FCF CAGR 5Y 1.6%
FCF CAGR 10Y -22.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y 71.0%
Revenue Growth Next 3Y N/A
Earnings Date Oct 28, 2026
EPS Estimate (next Q) -$0.15
EPS Growth Est (next Q) -38.9%
Revenue Est (next Q) $1.88M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $22
Price Target Upside 860.7%
Cash Flow
Operating Cash Flow $-18.38M
Free Cash Flow $-19.7M
Adj. Free Cash Flow $-20.45M
FCF Per Share -$0.61
OCF Per Share -$0.56
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-108K
Operating Income $-20.2M
EBITDA $-18.51M
Net Income $-18.42M
EPS (Diluted) -$0.69
Revenue / Employee N/A
Profit / Employee $-876.95K
Employees 21
Add to Watchlist
Select watchlists to add or remove INMB